Home
About
Publications Trends
Recent Publications
Expert Search
Archive
anticancer properties
How Do Pharmaceutical Drugs Exhibit Anticancer Properties?
Pharmaceutical drugs designed with anticancer properties often target specific aspects of cancer cell biology. Some mechanisms include:
Inhibition of Cell Proliferation
: Drugs like
methotrexate
and
5-fluorouracil
inhibit DNA synthesis, thereby preventing cancer cell division.
Induction of Apoptosis
: Agents like
doxorubicin
and
paclitaxel
can activate the intrinsic or extrinsic pathways of apoptosis, leading to cancer cell death.
Anti-angiogenesis
: Drugs like
bevacizumab
inhibit the formation of new blood vessels, thus starving the tumor of the nutrients and oxygen needed for its growth.
Frequently asked queries:
What are Anticancer Properties?
Why are Anticancer Properties Important?
What Natural Compounds Exhibit Anticancer Properties?
How Do Pharmaceutical Drugs Exhibit Anticancer Properties?
Can Diet Influence Anticancer Properties?
What are the Challenges in Utilizing Anticancer Properties?
Can Carcinogens Be Avoided?
Are There Any Nutrients to Avoid?
What is the Future of Cell Signaling Research in Cancer?
What Types of Data Should Be Backed Up?
What are Supportive Care Services?
Why is Enhanced Communication Important in Cancer Care?
What are the Challenges of Global Data Collaboration?
How can lifestyle changes impact cancer prevention and management?
What Mutations Affect SAC in Cancer?
What Regulations Exist to Protect Workers?
How do physicians diagnose cancer?
Can quitting smoking reverse the damage caused by smoking?
How to Request Accommodations?
How Can Communities Contribute to Cancer Awareness?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe